These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38782454)

  • 1. Prognostic Implications of
    Watanabe M; Fendler WP; Grafe H; Hirmas N; Hamacher R; Lanzafame H; Pabst KM; Hautzel H; Aigner C; Kasper S; von Tresckow B; Stuschke M; Kümmel S; Lugnier C; Hadaschik B; Grünwald V; Zarrad F; Siveke JT; Herrmann K; Weber M
    J Nucl Med; 2024 Jul; 65(7):1027-1034. PubMed ID: 38782454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Baseline
    Wu M; Wang Y; Yang Q; Wang X; Yang X; Xing H; Sang X; Li X; Zhao H; Huo L
    J Nucl Med; 2023 Oct; 64(10):1532-1539. PubMed ID: 37500263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using
    Pang Y; Zhao L; Meng T; Xu W; Lin Q; Wu H; Zhang J; Chen X; Sun L; Chen H
    J Nucl Med; 2023 Mar; 64(3):386-394. PubMed ID: 36215571
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Sahin E; Kus T; Aytekin A; Uzun E; Elboga U; Yilmaz L; Cayirli YB; Okuyan M; Cimen V; Cimen U
    J Nucl Med; 2024 Apr; 65(4):512-519. PubMed ID: 38485276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential utility of [
    Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The added value of [
    Liu Q; Shi S; Liu S; Xu X; Hu S; Zhang J; Wang C; Yu X; Song S
    Eur Radiol; 2023 Jul; 33(7):5007-5016. PubMed ID: 36809431
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Qin C; Shao F; Gai Y; Liu Q; Ruan W; Liu F; Hu F; Lan X
    J Nucl Med; 2022 Jan; 63(1):81-88. PubMed ID: 33863819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Added Value of
    Gu B; Xu X; Zhang J; Ou X; Xia Z; Guan Q; Hu S; Yang Z; Song S
    J Nucl Med; 2022 Jun; 63(6):875-881. PubMed ID: 34593594
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic significance of
    Arak H; Elboga U; Cayirli YB; Aytekin A
    Ann Nucl Med; 2024 Aug; 38(8):630-638. PubMed ID: 38684594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of [
    Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical Cancer.
    Wegen S; Roth KS; Weindler J; Claus K; Linde P; Trommer M; Akuamoa-Boateng D; van Heek L; Baues C; Schömig-Markiefka B; Schomäcker K; Fischer T; Drzezga A; Kobe C; Köhler C; Marnitz S
    Clin Nucl Med; 2023 Feb; 48(2):150-155. PubMed ID: 36607364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head-to-head comparison of [
    Ballal S; Yadav MP; Roesch F; Satapathy S; Moon ES; Martin M; Wakade N; Sheokand P; Tripathi M; Chandekar KR; Agarwal S; Sahoo RK; Rastogi S; Bal C
    Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):233-244. PubMed ID: 37642703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the clinical value of baseline [
    Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Li X; Huo L
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4036-4050. PubMed ID: 37493664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the role of 18 F-fluorodeoxyglucose PET/computed tomography and 68 Ga-labeled FAP inhibitor-04 PET/CT in patients with malignant mesothelioma.
    Güzel Y; Kömek H; Can C; Kaplan İ; Kepenek F; Ebinç S; Büyükdeniz MP; Gündoğan C; Oruç Z
    Nucl Med Commun; 2023 Jul; 44(7):631-639. PubMed ID: 37114422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superiority of [
    Fu L; Huang S; Wu H; Dong Y; Xie F; Wu R; Zhou K; Tang G; Zhou W
    Eur Radiol; 2022 Sep; 32(9):6281-6290. PubMed ID: 35380229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of
    Wang L; Tang G; Hu K; Liu X; Zhou W; Li H; Huang S; Han Y; Chen L; Zhong J; Wu H
    Radiology; 2022 Apr; 303(1):191-199. PubMed ID: 34981976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial clinical experience using
    Dadgar H; Norouzbeigi N; Assadi M; Al-Balooshi B; Al-Ibraheem A; Esmail AA; Marafi F; Haidar M; Al-Alawi HM; Omar Y; Usmani S; Cimini A; Arabi H; Zaidi H
    Hell J Nucl Med; 2024; 27(2):105-120. PubMed ID: 39097807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superior Tumor Detection for
    Pabst KM; Trajkovic-Arsic M; Cheung PFY; Ballke S; Steiger K; Bartel T; Schaarschmidt BM; Milosevic A; Seifert R; Nader M; Kessler L; Siveke JT; Lueckerath K; Kasper S; Herrmann K; Hirmas N; Schmidt HH; Hamacher R; Fendler WP
    J Nucl Med; 2023 Jul; 64(7):1049-1055. PubMed ID: 37024301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [
    Lin R; Lin Z; Chen Z; Zheng S; Zhang J; Zang J; Miao W
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2960-2971. PubMed ID: 35462566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast Activation Protein and Glycolysis in Lymphoma Diagnosis: Comparison of
    Chen X; Wang S; Lai Y; Wang G; Wei M; Jin X; Ding J; Zhang Y; Shi Y; Wang F; Zhu H; Yang Z; Wang X
    J Nucl Med; 2023 Sep; 64(9):1399-1405. PubMed ID: 37385675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.